Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring lung changes from prone positioning in ARDS with 3D electrical impedance tomography

Official title: Prone Position Assessment by 3D EIT in ARDS Patients

Run by Peking Union Medical College Hospital · NCT07083973 · Data updated 2026-11-12

This will see if turning adults on ventilators with ARDS onto their stomachs changes lung air distribution and blood flow as measured by 3D electrical impedance tomography, and it will compare 3D to 2D EIT for monitoring.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 31, 2024
Main results expectedOctober 31, 2026
Study endsDecember 30, 2026
Registry record updatedJanuary 26, 2026
Trial IDNCT07083973 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients with ARDS on mechanical ventilation who require prone positioning and have no contraindications to EIT (for example, no implantable cardiac devices, pumps, ribcage malformations, or pregnancy).

Probably not a fit

Patients not on mechanical ventilation, those with contraindications to EIT, pregnant patients, or those with chest wall deformities or implanted devices are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will record global and regional lung ventilation and perfusion changes when mechanically ventilated ARDS patients are placed in the prone position using 3D electrical impedance tomography (3D-EIT). Patients who are clinically judged to need prone positioning will be monitored before, during, and after proning without changing standard care. The study will directly compare measurements from conventional 2D-EIT with those from 3D-EIT to identify differences in monitoring performance. The work is conducted at the Department of Critical Care Medicine, Peking Union Medical College Hospital in Beijing and excludes patients with implanted devices, ribcage malformations, pregnancy, or age under 18.

Why it matters

Potential benefit: If successful, this could help clinicians better tailor prone positioning and monitor regional lung function noninvasively, potentially improving oxygenation and reducing ventilator-related injury.

How similar studies have gone: Prone positioning has been shown in prior trials to improve outcomes in moderate–severe ARDS, while electrical impedance tomography has been used for bedside monitoring and 3D-EIT is a newer, less-tested extension compared with established 2D-EIT.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients on mechanical ventilation.
* Diagnosis of ARDS was based on the Berlin definition
* Patients in need of prone position because of clinical condition

Exclusion Criteria:

* Under 18 years of age.
* Pregnant women;
* Ribcage malformation
* Any contraindication to the use of EIT (e.g. automatic implantable cardioverter defibrillator, and implantable pumps).

Where it's running

  • Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.